Abstract
| Original language | English |
|---|---|
| Journal | Liver International |
| DOIs | |
| Publication status | Published - Sep 16 2017 |
Fingerprint
Keywords
- Journal Article
Cite this
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation. / Martini, Silvia; Donato, Maria Francesca; Mazzarelli, Chiara; Rendina, Maria; Visco-Comandini, Ubaldo; Filì, Daniela; Gianstefani, Alice; Fagiuoli, Stefano; Melazzini, Mario; Montilla, Simona; Pani, Luca; Petraglia, Sandra; Russo, Pierluigi; Trotta, Maria Paola; Carrai, Paola; Caraceni, Paolo; group, ITACOPS study.
In: Liver International, 16.09.2017.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation
AU - Martini, Silvia
AU - Donato, Maria Francesca
AU - Mazzarelli, Chiara
AU - Rendina, Maria
AU - Visco-Comandini, Ubaldo
AU - Filì, Daniela
AU - Gianstefani, Alice
AU - Fagiuoli, Stefano
AU - Melazzini, Mario
AU - Montilla, Simona
AU - Pani, Luca
AU - Petraglia, Sandra
AU - Russo, Pierluigi
AU - Trotta, Maria Paola
AU - Carrai, Paola
AU - Caraceni, Paolo
AU - group, ITACOPS study
N1 - © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2017/9/16
Y1 - 2017/9/16
N2 - BACKGROUND & AIMS: This study aimed to assess the real-life clinical and virological outcomes of HCV waitlisted patients for liver transplantation (LT) who received sofosbuvir/ribavirin (SOF/R) within the Italian compassionate use program.METHODS: Clinical and virological data were collected in 224 patients with decompensated cirrhosis and/or hepatocellular carcinoma (HCC) receiving daily SOF/R until LT or up a maximum of 48 weeks.RESULTS: Of 100 transplanted patients, 51 were HCV-RNA negative for >4 weeks before LT (SVR12: 88%) and 49 negative for
AB - BACKGROUND & AIMS: This study aimed to assess the real-life clinical and virological outcomes of HCV waitlisted patients for liver transplantation (LT) who received sofosbuvir/ribavirin (SOF/R) within the Italian compassionate use program.METHODS: Clinical and virological data were collected in 224 patients with decompensated cirrhosis and/or hepatocellular carcinoma (HCC) receiving daily SOF/R until LT or up a maximum of 48 weeks.RESULTS: Of 100 transplanted patients, 51 were HCV-RNA negative for >4 weeks before LT (SVR12: 88%) and 49 negative for
KW - Journal Article
U2 - 10.1111/liv.13588
DO - 10.1111/liv.13588
M3 - Article
JO - Liver International
JF - Liver International
SN - 1478-3223
ER -